Xtant Medical Holdings, Inc.
General ticker "XTNT" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $87.7M (TTM average)
Xtant Medical Holdings, Inc. does not follow the US Stock Market performance with the rate: -7.6%.
Estimated limits based on current volatility of 1.2%: low 0.47$, high 0.48$
Factors to consider:
- Total employees count: 232 (+7.9%) as of 2024
- US accounted for 90.0% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Increasing losses and financing needs, Dependence on key suppliers, Litigation risks, Market competition, Regulatory and compliance
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.48$, 1.22$]
- 2026-12-31 to 2027-12-31 estimated range: [0.55$, 1.34$]
Financial Metrics affecting the XTNT estimates:
- Positive: with PPE of 25.4 at the end of fiscal year the price was very low
- Positive: 6.59 < Operating cash flow per share per price, % of 11.51
- Positive: -5.39 < Operating profit margin, % of 5.44
- Positive: Investing cash flow per share per price, % of 7.25 > -0.60
- Positive: 1.81 < Return on assets ratio (scaled to [-100,100]) of 5.02
- Positive: 42.59 < Shareholder equity ratio, % of 54.12 <= 64.29
- Negative: negative Industry operating cash flow (median)
- Negative: Industry earnings per price (median), % of -1.58 <= 0
Short-term XTNT quotes
Long-term XTNT plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $91.30MM | $117.27MM | $133.93MM |
| Operating Expenses | $101.46MM | $129.34MM | $126.64MM |
| Operating Income | $-10.16MM | $-12.07MM | $7.28MM |
| Non-Operating Income | $9.12MM | $-4.19MM | $-0.28MM |
| Interest Expense | $2.94MM | $4.16MM | $3.67MM |
| R&D Expense | $1.34MM | $2.38MM | $2.10MM |
| Income(Loss) | $-1.04MM | $-16.26MM | $7.00MM |
| Taxes | $-1.70MM | $0.19MM | $2.03MM |
| Net Income(Loss)* | $0.66MM | $-16.45MM | $4.97MM |
| Stockholders Equity | $51.35MM | $42.96MM | $50.95MM |
| Inventory | $36.88MM | $38.63MM | $30.26MM |
| Assets | $92.61MM | $93.84MM | $94.14MM |
| Operating Cash Flow | $-9.52MM | $-11.90MM | $12.55MM |
| Capital expenditure | $1.46MM | $4.11MM | $2.38MM |
| Investing Cash Flow | $-24.78MM | $-3.73MM | $7.90MM |
| Financing Cash Flow | $19.69MM | $16.07MM | $-9.57MM |
| Earnings Per Share** | $0.01 | $-0.12 | $0.04 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.